MCI and AD
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD)
13
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
12
Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data
12
Re-evaluation of soluble APP-α and APP-β in cerebrospinal fluid as potential biomarkers for early diagnosis of dementia disorders
9
Souvenaid in the management of mild cognitive impairment: an expert consensus opinion
11
Minimally invasive biomarker confirms glial activation present in Alzheimer's disease: a preliminary study
5
Study protocol: Language profile in mild cognitive impairment: A prospective study
5
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease
8
Calmodulin levels in blood cells as a potential biomarker of Alzheimer’s disease
10
Identification of peripheral inflammatory markers between normal control and Alzheimer's disease
6
Plasma protein profiling of Mild Cognitive Impairment and Alzheimer’s disease using iTRAQ quantitative proteomics
13
An overview of quantitative magnetic resonance imaging analysis studies in the assessment of alzheimer’s disease
7
MILD COGNITIVE IMPAIRMENT: WHATS NEW ABOUT?
8
The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
14
<p>MMSE Subscale Scores as Useful Predictors of AD Conversion in Mild Cognitive Impairment</p>
9
Alzheimer's Disease: What Is Known About Delaying Or Preventing Its Onset Or Progression?
7
Detection of Alzheimer\\\\\\\\\\\\\\\'s Disease using Multitracer Positron Emission Tomography Imaging
6
PubMedCentral-PMC5372170.pdf
11
Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer’s disease
8
Relationship between oxysterols and mild cognitive impairment in the elderly: a case–control study
6